160 related articles for article (PubMed ID: 12044894)
1. Importance of platelets in VEGF-mediated angiogenesis in tumors.
Salgado R; Benoy I; Dirix L; Vermeulen P; Van Marck E
FEBS Lett; 2002 Jun; 520(1-3):182. PubMed ID: 12044894
[No Abstract] [Full Text] [Related]
2. Vascular endothelial growth factor and its receptor correlate with angiogenesis and survival in pulmonary adenocarcinoma.
Takanami I; Tanaka F; Hashizume T; Kodaira S
Anticancer Res; 1997; 17(4A):2811-4. PubMed ID: 9252720
[TBL] [Abstract][Full Text] [Related]
3. Endothelial receptor tyrosine kinases involved in blood vessel development and tumor angiogenesis.
Breier G
Adv Exp Med Biol; 2000; 476():57-66. PubMed ID: 10949655
[No Abstract] [Full Text] [Related]
4. Endothelial receptor tyrosine kinases involved in angiogenesis.
Mustonen T; Alitalo K
J Cell Biol; 1995 May; 129(4):895-8. PubMed ID: 7538139
[No Abstract] [Full Text] [Related]
5. Biological properties of VEGF/VPF receptors.
Terman BI; Dougher-Vermazen M
Cancer Metastasis Rev; 1996 Jun; 15(2):159-63. PubMed ID: 8842487
[No Abstract] [Full Text] [Related]
6. Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2.
Vajkoczy P; Farhadi M; Gaumann A; Heidenreich R; Erber R; Wunder A; Tonn JC; Menger MD; Breier G
J Clin Invest; 2002 Mar; 109(6):777-85. PubMed ID: 11901186
[TBL] [Abstract][Full Text] [Related]
7. Receptor links blood vessels, axons.
Roush W
Science; 1998 Mar; 279(5359):2042. PubMed ID: 9537914
[No Abstract] [Full Text] [Related]
8. [New molecular target of cancer therapy--angiogenesis regulator VEGF].
Toi M; Ueno T; Tominaga T
Gan To Kagaku Ryoho; 1997 Dec; 24(15):2202-6. PubMed ID: 9422062
[TBL] [Abstract][Full Text] [Related]
9. KDR activation in astrocytic neoplasms.
Carroll RS; Zhang J; Bello L; Melnick MB; Maruyama T; McL Black P
Cancer; 1999 Oct; 86(7):1335-41. PubMed ID: 10506722
[TBL] [Abstract][Full Text] [Related]
10. Gene expression of vascular endothelial growth factor and its receptors and angiogenesis in bronchial asthma.
Hoshino M; Nakamura Y; Hamid QA
J Allergy Clin Immunol; 2001 Jun; 107(6):1034-8. PubMed ID: 11398081
[TBL] [Abstract][Full Text] [Related]
11. Microvessel density, vascular endothelial growth factor and its receptors Flt-1 and Flk-1/KDR in hepatocellular carcinoma.
Ng IO; Poon RT; Lee JM; Fan ST; Ng M; Tso WK
Am J Clin Pathol; 2001 Dec; 116(6):838-45. PubMed ID: 11764072
[TBL] [Abstract][Full Text] [Related]
12. Induction of VEGF and VEGF receptors in the spinal cord after mechanical spinal injury and prostaglandin administration.
Sköld M; Cullheim S; Hammarberg H; Piehl F; Suneson A; Lake S; Sjögren A; Walum E; Risling M
Eur J Neurosci; 2000 Oct; 12(10):3675-86. PubMed ID: 11029637
[TBL] [Abstract][Full Text] [Related]
13. Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1-Flt1 and VEGF-R2-Flk1/KDR) in non-small cell lung carcinomas (NSCLCs): correlation with angiogenesis and survival.
Decaussin M; Sartelet H; Robert C; Moro D; Claraz C; Brambilla C; Brambilla E
J Pathol; 1999 Aug; 188(4):369-77. PubMed ID: 10440746
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of both paracrine and autocrine VEGF/ VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias.
Dias S; Hattori K; Heissig B; Zhu Z; Wu Y; Witte L; Hicklin DJ; Tateno M; Bohlen P; Moore MA; Rafii S
Proc Natl Acad Sci U S A; 2001 Sep; 98(19):10857-62. PubMed ID: 11553814
[TBL] [Abstract][Full Text] [Related]
15. The role of vascular endothelial growth factor in angiogenesis.
Ferrara N; Gerber HP
Acta Haematol; 2001; 106(4):148-56. PubMed ID: 11815711
[TBL] [Abstract][Full Text] [Related]
16. [Expression and subtype analysis of vascular endothelial growth factor (VEGF) and its receptor (flt-1) in human ovarian tumors].
Ishii Y
Nihon Sanka Fujinka Gakkai Zasshi; 1995 Feb; 47(2):133-40. PubMed ID: 7535833
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development.
Samaniego F; Markham PD; Gendelman R; Watanabe Y; Kao V; Kowalski K; Sonnabend JA; Pintus A; Gallo RC; Ensoli B
Am J Pathol; 1998 Jun; 152(6):1433-43. PubMed ID: 9626048
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: implications for measurement of circulating VEGF levels in clinical disease.
Webb NJ; Bottomley MJ; Watson CJ; Brenchley PE
Clin Sci (Lond); 1998 Apr; 94(4):395-404. PubMed ID: 9640345
[TBL] [Abstract][Full Text] [Related]
19. Expression of vascular endothelial growth factor (VEGF) and its receptors is regulated in eyes with intra-ocular tumours.
Stitt AW; Simpson DA; Boocock C; Gardiner TA; Murphy GM; Archer DB
J Pathol; 1998 Nov; 186(3):306-12. PubMed ID: 10211121
[TBL] [Abstract][Full Text] [Related]
20. The vascular endothelial growth factor family: signalling for vascular development.
Stacker SA; Achen MG
Growth Factors; 1999; 17(1):1-11. PubMed ID: 10495958
[No Abstract] [Full Text] [Related]
[Next] [New Search]
